1 - 25 of 72 results for author:"Ralston S.H." in Literature citations
Results Customize
› Repeat search in UniProtKB (7)
| A class III semaphorin (Sema3e) inhibits mouse osteoblast migration and decreases osteoclast formation in vitro. Hughes A., Kleine-Albers J., Helfrich M.H., Ralston S.H., Rogers M.J. Calcif. Tissue Int. 90:151-162(2012) · Mapped (4) |
| A variant in MCF2L is associated with osteoarthritis. arcOGEN Consortium Am. J. Hum. Genet. 89:446-450(2011) · Mapped (7) |
| A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice. Daroszewska A., van 't Hof R.J., Rojas J.A., Layfield R., Landao-Basonga E., Rose L., Rose K., Ralston S.H. Hum. Mol. Genet. 20:2734-2744(2011) · Mapped (3) |
| Signal peptide mutations in RANK prevent downstream activation of NF-kappaB. Crockett J.C., Mellis D.J., Shennan K.I., Duthie A., Greenhorn J., Wilkinson D.I., Ralston S.H., Helfrich M.H., Rogers M.J. J. Bone Miner. Res. 26:1926-1938(2011) · Mapped (6) |
| The type 2 cannabinoid receptor regulates bone mass and ovariectomy-induced bone loss by affecting osteoblast differentiation and bone formation. Sophocleous A., Landao-Bassonga E., Van't Hof R.J., Idris A.I., Ralston S.H. Endocrinology 152:2141-2149(2011) · Mapped (1) |
| Meta-analysis of genome-wide association studies confirms a susceptibility locus for knee osteoarthritis on chromosome 7q22. arcOGEN Consortium Ann. Rheum. Dis. 70:349-355(2011) · Mapped (21) |
| Polymorphisms in the 5' flank of COL1A1 gene and osteoporosis: meta-analysis of published studies. Jin H., Evangelou E., Ioannidis J.P., Ralston S.H. Osteoporos Int 22:911-921(2011) · Mapped (6) |
| Genetic variation in the TNFRSF11A gene encoding RANK is associated with susceptibility to Paget's disease of bone. Chung P.Y., Beyens G., Riches P.L., Van Wesenbeeck L., de Freitas F., Jennes K., Daroszewska A., Fransen E., Boonen S., Geusens P. et al. J. Bone Miner. Res. 25:2592-2605(2010) · Mapped (6) |
| Mutations of SQSTM1 are associated with severity and clinical outcome in paget disease of bone. Visconti M.R., Langston A.L., Alonso N., Goodman K., Selby P.L., Fraser W.D., Ralston S.H. J. Bone Miner. Res. 25:2368-2373(2010) · Mapped (3) |
| Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone. Albagha O.M., Visconti M.R., Alonso N., Langston A.L., Cundy T., Dargie R., Dunlop M.G., Fraser W.D., Hooper M.J., Isaia G. et al. Nat. Genet. 42:520-524(2010) · Mapped (14) |
| Mutant p62/SQSTM1 UBA domains linked to Paget's disease of bone differ in their abilities to function as stabilization signals. Heinen C., Garner T.P., Long J., Bottcher C., Ralston S.H., Cavey J.R., Searle M.S., Layfield R., Dantuma N.P. FEBS Lett. 584:1585-1590(2010) · Mapped (3) |
| Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Genetic Factors for Osteoporosis (GEFOS) Consortium Nat. Genet. 41:1199-1206(2009) · Mapped (125) |
| Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells. Idris A.I., Sophocleous A., Landao-Bassonga E., Canals M., Milligan G., Baker D., van't Hof R.J., Ralston S.H. Cell Metab. 10:139-147(2009) · Mapped (2) |
| Promoter and intron 1 polymorphisms of COL1A1 interact to regulate transcription and susceptibility to osteoporosis. Jin H., van't Hof R.J., Albagha O.M., Ralston S.H. Hum. Mol. Genet. 18:2729-2738(2009) · Mapped (6) |
| LRP5 Polymorphisms and response to risedronate treatment in osteoporotic men. Kruk M., Ralston S.H., Albagha O.M. Calcif. Tissue Int. 84:171-179(2009) · Mapped (1) |
| Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor. Idris A.I., Sophocleous A., Landao-Bassonga E., van't Hof R.J., Ralston S.H. Endocrinology 149:5619-5626(2008) · Mapped (1) |
| Vitamin K1 intake is associated with higher bone mineral density and reduced bone resorption in early postmenopausal Scottish women: no evidence of gene-nutrient interaction with apolipoprotein E polymorphisms. Macdonald H.M., McGuigan F.E., Lanham-New S.A., Fraser W.D., Ralston S.H., Reid D.M. Am. J. Clin. Nutr. 87:1513-1520(2008) · Mapped (5) |
| Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. van Meurs J.B., Trikalinos T.A., Ralston S.H., Balcells S., Brandi M.L., Brixen K., Kiel D.P., Langdahl B.L., Lips P., Ljunggren O. et al. JAMA 299:1277-1290(2008) · Mapped (1) |
| SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Vitart V., Rudan I., Hayward C., Gray N.K., Floyd J., Palmer C.N., Knott S.A., Kolcic I., Polasek O., Graessler J. et al. Nat. Genet. 40:437-442(2008) · UniProtKB (1) |
| Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study. Langdahl B.L., Uitterlinden A.G., Ralston S.H., Trikalinos T.A., Balcells S., Brandi M.L., Scollen S., Lips P., Lorenc R., Obermayer-Pietsch B. et al. Bone 42:969-981(2008) · Mapped (9) |
| ER stress-mediated apoptosis in a new mouse model of osteogenesis imperfecta. Lisse T.S., Thiele F., Fuchs H., Hans W., Przemeck G.K., Abe K., Rathkolb B., Quintanilla-Martinez L., Hoelzlwimmer G., Helfrich M. et al. PLoS Genet. 4:e7-e7(2008) · Mapped (3) |
| Low body mass not vitamin D receptor polymorphisms predict osteoporosis in patients with inflammatory bowel disease. Noble C.L., McCullough J., Ho W., Lees C.W., Nimmo E., Drummond H., Bear S., Hannan J., Millar C., Ralston S.H. et al. Aliment. Pharmacol. Ther. 27:588-596(2008) · Mapped (6) |
| Ubiquitin recognition by the ubiquitin-associated domain of p62 involves a novel conformational switch. Long J., Gallagher T.R., Cavey J.R., Sheppard P.W., Ralston S.H., Layfield R., Searle M.S. J. Biol. Chem. 283:5427-5440(2008) · UniProtKB (1) · Mapped (2) |
| PTHR1 polymorphisms influence BMD variation through effects on the growing skeleton. Vilarino-Guell C., Miles L.J., Duncan E.L., Ralston S.H., Compston J.E., Cooper C., Langdahl B.L., Maclelland A., Pols H.A., Reid D.M. et al. Calcif. Tissue Int. 81:270-278(2007) · Mapped (3) |
| Identification of sex-specific associations between polymorphisms of the osteoprotegerin gene, TNFRSF11B, and Paget's disease of bone. Beyens G., Daroszewska A., de Freitas F., Fransen E., Vanhoenacker F., Verbruggen L., Zmierczak H.G., Westhovens R., Van Offel J., Ralston S.H. et al. J. Bone Miner. Res. 22:1062-1071(2007) · Mapped (1) |